Introduction
============

Endometritis is an inflammation of the uterine internal lining that develops in many cows soon after parturition ("calving").[@b1-bbi-8-2014-045] Clinical endometritis is characterized by the presence of a purulent uterine discharge (\>50% pus) in the first 21 days postpartum or mucupurulent discharge (50% pus, 50% mucus) after 26 days postpartum.[@b2-bbi-8-2014-045] It affects approximately 20% of lactating dairy cows, with a prevalence varying from 5% to \>30% in certain herds.[@b3-bbi-8-2014-045],[@b4-bbi-8-2014-045] Subclinical endometritis (SCE) is typically defined as an elevated percentage of polymorphonuclear (PMN) cells in the uterus.[@b5-bbi-8-2014-045],[@b6-bbi-8-2014-045] The SCE is characterized by the presence of \>18% PMN in uterine cytology samples collected at 21 to 33 days postpartum, or \>10% PMN in samples collected at 34 to 47 days postpartum.[@b2-bbi-8-2014-045] The incidence of SCE is the most prevalent of all uterine pathologies, affecting approximately 30% of lactating dairy cows, with a prevalence varying from 11% to \>70% in certain herds.[@b7-bbi-8-2014-045]--[@b9-bbi-8-2014-045] During the endometritis process, dairy cows experience a decrease in blood PMN function when compared with healthy cows.[@b5-bbi-8-2014-045] Furthermore, cows afflicted with endometritis have reduced fertility[@b10-bbi-8-2014-045],[@b11-bbi-8-2014-045] and may have an impairment of both the innate and adaptive immune system[@b12-bbi-8-2014-045],[@b13-bbi-8-2014-045] rendering them more susceptible to other diseases.

Elevated non-esterified fatty acids (NEFA), beta-hydroxybutyrate (BHBA) and lower glucose and calcium plasma concentrations are some of the biomarkers often associated with periparturient immune function suppression and uterine health disorders.[@b5-bbi-8-2014-045],[@b14-bbi-8-2014-045],[@b15-bbi-8-2014-045] However, in a recent study with grazing cows, no change was observed in plasma concentrations of NEFA, BHBA, and glucose in cows with signs of SCE, whereas, a lower albumin plasma concentration indicated impaired liver function.[@b16-bbi-8-2014-045] Consistent with this, other studies have reported an association between higher plasma concentrations of positive acute-phase proteins and clinical endometritis,[@b17-bbi-8-2014-045],[@b18-bbi-8-2014-045] suggesting a pro-inflammatory response involving the liver in affected cows.

In addition to the liver, recent research on the immune role of adipose depots confirmed that the tissue (and resident immune cells) is capable of synthesizing and releasing adipokines, chemokines, cytokines and inflammatory mediators upon exposure to an inflammatory condition.[@b30-bbi-8-2014-045],[@b66-bbi-8-2014-045] This peculiarity of the adipose tissue might be relevant during early lactation when there is extensive mobilization of all fat depots.[@b19-bbi-8-2014-045] Therefore, knowledge of both hepatic and adipocyte responses to a pro-inflammatory condition, such as SCE, might be important in understanding the cow's systemic adaptations to the disease. It is noteworthy that a recent study demonstrated that SCE leads to alterations in gene expression profiles of both endometrium and embryo, hence, underscoring the potential for localized uterine inflammation to affect other tissues or cells.[@b20-bbi-8-2014-045]

Previous work focusing on specific target genes associated with inflammation in dairy cows has demonstrated the relevance of the molecular approach in helping uncover the cellular processes induced by endometritis.[@b21-bbi-8-2014-045] However, large-scale gene expression profiling (ie, transcriptomics) coupled with bioinformatics are better suited for integrating host-tissue responses to changes in disease state.[@b22-bbi-8-2014-045] Therefore, in addition to blood metabolites and enzymes, we sought to study transcriptome-wide changes in liver and subcutaneous adipose tissue using a bovine microarray and bioinformatics analysis.

Methods
=======

Animal experimental design
--------------------------

All animal procedures were approved by the Ruakura Animal Ethics Committee (Hamilton, New Zealand). Cows grazed pasture, managed in an intensive rotational manner.[@b23-bbi-8-2014-045] Uterine sampling was undertaken twice a week between 22 and 25 days postpartum for evaluation of polymorphonuclear cells (PMN) and uterine bacteriology. Cows with calving difficulties, retained placenta, or those treated with antibiotics during the first 30 days postpartum were excluded from the study.

Selection of cows
-----------------

The criterion for cow selection was based on the percentage of PMN in the uterine swab. Cows with no PMN or macrophages identified were classified as no uterine infection (NUI), whereas cows with \>18% PMN with an absence of macrophages were classified as SCE. Cows were paired (a NUI and a SCE cow), ensuring a balance (as best as possible) for calving date, breed, and age.[@b6-bbi-8-2014-045]

Body condition score (BCS) and milk yield
-----------------------------------------

Body condition was measured on the New Zealand 1 to 10 scale, where 1 was emaciated and 10 obese.[@b24-bbi-8-2014-045] Individual body condition and body weight were measured weekly pre- and post-calving. Individual milk yields (kg/d) were recorded using the DeLaval Harmony and ALPRO® milking system with milking point controller (MPC™) at each bail recording for each cow.

Blood metabolites
-----------------

Blood was collected by jugular venipuncture into multiple evacuated blood tubes (EDTA, heparin, clot-activator; Becton and Dickinson, New York, USA) on the day of slaughter and immediately placed in iced water. After collection, samples were centrifuged within 30 min (12 min at 1,500 × g) and the aspirated plasma and serum fractions were stored at −20 °C until further analysis. Plasma samples were analyzed for concentrations of NEFA (WAKO, Osaka, Japan), Mg (xlidyl blue reaction), albumin (bromocresol green reaction at pH 4.1), and total protein (Biuret reaction method), with globulin calculated by subtracting albumin from total protein. Glutamate dehydrogenase (GDH, IU/L; catalyzing activity of NADH-dependent conversion of α-ketoglutarate to glutamate), and aspartate aminotransferase (AST, IU/L; catalyzing activity of transamination of L-aspartate to oxalo-acetate) were also analyzed. All assays were colorimetric, and performed at 37 °C using a Roche Modular P800 analyzer (Roche Diagnostics, Indianapolis, IN) by Gribbles Veterinary Pathology Ltd (Hamilton, New Zealand). The inter-assay and intra-assay CV for all assays were ≤11% and ≤2%, respectively.

Tissues collection and RNA extraction
-------------------------------------

Animals (6 in each NUI and SCE) were slaughtered at a commercial abattoir (AgResearch Abattoir, Hamilton, New Zealand) at 29 days postpartum (range of 27--31 days). Samples of liver and subcutaneous adipose tissue from the shoulder (\~1.0 g) were stored in 2 mL cryo-vials and placed in liquid nitrogen. All tissue samples were subsequently stored at −80 °C within 30 to 50 min after exsanguination. RNA was extracted from frozen tissue using established protocols in our laboratory.[@b25-bbi-8-2014-045] Briefly, tissue was weighed (\~0.3--0.5 g) and placed in a 15 mL centrifuge tube (Corning Inc.®, Cat. No. 430052, Corning, NY, USA) containing 1 μL linear acrylamide (Ambion® Cat. No. 9520, Austin, TX, USA) as a co-precipitant, and 5 mL of ice-cold Trizol reagent (Invitrogen Corp., Carlsbad, CA, USA). Samples were homogenized using a hand-held polytron homogenizer. This extraction procedure also utilizes acid-phenol chloroform (Ambion® Cat. No. 9720, TX, USA), which removes residual DNA. Any residual genomic DNA was removed from RNA with DNase using RNeasy Mini Kit columns (Qiagen, Hilden, Germany). The RNA concentration was measured using a Nano-Drop ND-1000 spectrophotometer (Nano-Drop Technologies, Wilmington, DE, USA). The purity of RNA (A~260~/A~280~) for all samples was above 1.81. The quality of RNA was evaluated using the Agilent Bioanalyzer system (Agilent 2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA, USA). The average RNA integrity number for samples was 8.0 ± 0.4.

Microarrays
-----------

Transcript profiling was conducted using a bovine oligonucleotide microarray containing \~13,000 unique elements described elsewhere.[@b25-bbi-8-2014-045] The methods used for hybridization and scanning were consistent with those of Loor et al.[@b25-bbi-8-2014-045] Annotation was based on similarity searches using BLASTN and TBLASTX against human and mouse UniGene databases and the human genome. Briefly, cDNA was labeled with Cy3 and Cy5 fluorescent dyes (Amersham, Piscataway, NJ). A dye-swap loop microarray design was used; briefly, the Cy3 labeled cDNA (T1) from SCE was co-hybridized with Cy5 labeled cDNA (C1) from NUI liver samples to generate fluorescence ratios as a measurement of relative expression across the treatments. Moreover, in the next microarray slide the Cy3-labeled cDNA (C1) of the same NUI sample was co-hybridized with another Cy5-labeled (T2) SCE sample to form a loop ([Suppl 1](#s1-bbi-8-2014-045){ref-type="supplementary-material"}. [Fig. 1](#f1-bbi-8-2014-045){ref-type="fig"}).

Quantitative PCR
----------------

Quantitative real-time PCR (qPCR) was performed to verify microarray results and analyze other genes of interest. Protocols for primer design, primer testing, selection of internal control genes (ICG) for normalization, and details of the qPCR analysis were as previously described.[@b27-bbi-8-2014-045] Detailed information of the primers is provided in [Suppl 1](#s1-bbi-8-2014-045){ref-type="supplementary-material"}. [Table 1](#t1-bbi-8-2014-045){ref-type="table"} and [2](#t2-bbi-8-2014-045){ref-type="table"}. Briefly, for liver tissue the genes analyzed by qPCR included transcription regulators (*PPARA, RXRA, NFIL3*), genes associated with fatty acid oxidation (*ACOX1, CPT1A*), ketogenesis (*HMGCS2*), growth hormones/IGF-1-axis (total *GHR, IGF1*), cytokines/inflammatory mediators (*IL10, IL1B, TNF, STAT3, SOCS2, STAT5B*), acute-phase proteins (*ORM1, HP*, *SAA3, PON1*), oxidative stress (*SOD*1*, GPX*1), hepatokines (*ANGPTL4, FGF21*) and insulin signaling (*AKT1*). These targets are central components of the pathways under study.[@b28-bbi-8-2014-045] The final data were normalized using the geometric mean (V2/3 = 0.20; geNorm) of ubiquitously-expressed transcript (*UXT*), glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*), and ribosomal protein S9 (*RPS*9), detailed information of qPCR efficiency and% relative RNA abundance can be found in [Suppl 1](#s1-bbi-8-2014-045){ref-type="supplementary-material"}. [Table 3](#t3-bbi-8-2014-045){ref-type="table"}.

For subcutaneous adipose tissue the genes analyzed by qPCR included transcription regulators (*RXRA, PPARG, SREBF1, TP53, NFIL3*), lipogenic enzymes (*LP1N1, SCD, FASN*, *PLIN2*), lipolysis (*ABHD5, LIPE, PNPLA2*), insulin signaling pathway (*GHR, SLC*2*A*4*, IRS1*), adipokines (*ADIPOQ, ANGPTL4, CCL5, BCL2, CCL2*), cytokines/inflammatory mediators (*IL6, HP, SAA3, NFKB1, STAT3*) and oxidative stress (*SOD2*). These targets are central components of the pathways under study and some have been reported to respond to inflammatory stimuli.[@b29-bbi-8-2014-045],[@b30-bbi-8-2014-045] The final data were normalized using the geometric mean (V2/3 = 0.20; geNorm) of FUN14 domain containing 2 (*FUNDC2*), secretion regulating guanine nucleotide exchange factor (*SERGEF*), solute carrier family 35 (adenosine 3′-phospho 5′-phosphosulfate transporter), member B2 (*SLC35B2*), and prokineticin receptor 1 (*PROKR1*). The detailed information for qPCR efficiency and% relative RNA abundance of the measured genes is provided in [Suppl 1](#s1-bbi-8-2014-045){ref-type="supplementary-material"}. [Table 4](#t4-bbi-8-2014-045){ref-type="table"}.

Statistical analysis
--------------------

Data from a total of 12 microarrays were normalized for dye and microarray effects (ie, Lowess normalization and microarray centering) and used for statistical analysis.[@b25-bbi-8-2014-045] Data were analyzed using the Proc MIXED procedure of SAS (SAS, SAS Inst. Inc., Cary, NC). Fixed effects were treatment (SCE = infection and NUI = control), and random effects included cow and microarray. Quantitative PCR data normalized relative to the internal control genes were first log~2~-transformed prior to statistical analysis. Differentially expressed genes were determined as reported recently[@b31-bbi-8-2014-045] using a cutoff of *P* \< 0.05 and a fold-change greater or lower than 1.5 in the comparison of SCE versus NUI. Validation for this approach, which does not take into account multiple testing corrections, was reported previously.[@b26-bbi-8-2014-045],[@b102-bbi-8-2014-045]

Bioinformatics
--------------

The entire microarray data set with associated statistical *P*-values was imported into the Database for Annotation, Visualization and Integrated Discovery (DAVID)[@b32-bbi-8-2014-045] analyses tools (<http://david.abcc.ncifcrf.gov>) and Kyoto Encyclopedia of Genes and Genomes (KEGG) software to obtain significant gene ontology (GO) terms in different categories (molecular functions, biological pathways and cellular components). The whole annotated microarray was used as the reference dataset (ie, background) for pathway analysis. In other words, only pathways represented by the genes on the microarray platform were used for the bioinformatics analysis.

Functional enrichment analysis
------------------------------

The functional enrichment analysis was performed using the Dynamic Impact Approach (DIA).[@b33-bbi-8-2014-045] The DIA is a novel functional analysis tool that allows visualizing the impact and the direction of the impact of DEG on several annotation databases including GO and KEGG pathways. The DIA has been described in detail previously;[@b33-bbi-8-2014-045] briefly, the alterations in expression of proteins in a metabolic or signaling pathway determine the flux (or overall direction, ie, activation/up-regulation, inhibition/down-regulation, or no change) of the respective pathway, whereas, the extent of the impact on a pathway is directly depicted by the number of proteins affected by a particular treatment. The cumulative flux of pathways is determined by total number of up-regulated and down-regulated proteins involved in a pathway. If the ratio of up-regulated/down-regulated = 1, the flux can be taken as unchanged overall, regardless of the fact that the treatment had a large impact on the pathway.[@b34-bbi-8-2014-045] The impact and the flux for KEGG pathways were calculated for only those terms which were represented by at least 30% in the microarray compared with the whole annotated bovine genome.

Results
=======

Body condition score (BCS), milk production and blood metabolites
-----------------------------------------------------------------

There was a postpartum (*P* \< 0.01) decrease in BCS, but no effect of health status was observed (*P* = 0.45) ([Fig. 1](#f1-bbi-8-2014-045){ref-type="fig"}). There were no health status × week relative to parturition interactions (*P* = 0.76) for BCS. Irrespective of health status (*P* = 0.78), milk yield increased between day 1 and 29 postpartum (*P* = 0.07). However, there was a trend (*P* = 0.07) for an interaction of health status × week for daily milk yield due to healthy cows producing more milk through the first 3 weeks postpartum ([Fig. 1](#f1-bbi-8-2014-045){ref-type="fig"}). There was no effect (*P* = 0.11 to 0.70) of health status on the concentration of blood biomarkers measured ([Table 1](#t1-bbi-8-2014-045){ref-type="table"}).

Differential expression of genes using microarrays
--------------------------------------------------

The analysis of microarray data revealed a total of 97 differentially expressed genes (DEG; *P* \< 0.05, fold-change cut off ≥1.5 or ≤1/1.5 SCE vs. NUI) in liver (35 down-regulated, 62 up-regulated) ([Table 2](#t2-bbi-8-2014-045){ref-type="table"}). The primary up-regulated DEG included genes involved in steroid biosynthesis (*CYP11A1*), acute-phase and pro-inflammatory proteins synthesis (*IL1RAP*), GTPase activity and leukemogenesis (*RGS2*), beta component of fibrinogen (*FGB*), lipid uptake, transport and metabolism (*FABP5, APOC4*), oxidative phosphorylation (*ATP5A1, ATP5G3*) and cell growth (*GRN*) and complement system (*C1QA*). Whereas, the primary down-regulated DEG included genes involved in peptide hormone binding (*NPR3*), immune system and inflammation (*IFITM3, CCR4, AOX1*), breakdown of extracellular matrix (*MMP7*), ATP binding (*CKM*), and fatty acid catabolism (*ACOT7*) ([Table 2](#t2-bbi-8-2014-045){ref-type="table"}).

Microarray analysis of adipose uncovered 144 DEG (*P* \< 0.05, fold-change cut off ≥1.5 or ≤1/1.5 SCE vs. NUI) (82 down-regulated, 62 up-regulated) ([Table 3](#t3-bbi-8-2014-045){ref-type="table"}). The primary up-regulated DEG included genes involved in endogenous cholesterol synthesis (*SREBF2*), NAD metabolism (*NUDT12*, *UGDH*), cytokine-mediated signaling (*IRF2*), oxidative phosphorylation (*NDUFS6*), and insulin signaling (*AKT2*). Whereas, the primary down-regulated DEG included genes involved in golgi complex morphology and function (*CORO7*), cytokine-mediated signaling (*IFITM3*), calcium ion binding (*ANXA6*), oxidative phosphorylation (*NDUFS7*), and apoptosis (*HIC1*) ([Table 3](#t3-bbi-8-2014-045){ref-type="table"}).

Differential expression of genes by qPCR
----------------------------------------

Expression analysis by qPCR in liver tissue revealed a significant up-regulation of total *GHR* (somatotropic axis), *HP* (acute-phase protein), *SOD2* and *GPX1* (oxidative stress), and *RXRA* (fatty acid oxidation) in cows with SCE ([Table 4](#t4-bbi-8-2014-045){ref-type="table"}). In subcutaneous adipose tissue, infection was associated with up-regulation of *TP53* (transcription factor), *IL6* and *CCL2* (adipokines), and tended (*P* = 0.16) to increase *STAT3* (inflammation). The expression of the lipid droplet-associated gene *PLIN2*, *SLC2A4* and *IRS1* (insulin signaling), and *SOD2* (oxidative stress) in adipose was down-regulated in SCE ([Table 5](#t5-bbi-8-2014-045){ref-type="table"}).

Functional analysis of KEGG pathways using DIA
----------------------------------------------

### Liver

A functional analysis of DEG (*P* \< 0.05, fold-change cut off ≥1.5 or ≤1/1.5 SCE vs. NUI) was undertaken with DIA using the KEGG pathway database. In liver, the metabolic pathways and organismal systems categories were the most impacted due to SCE; whereas, environmental information processing, genetic information processing and cellular processes were the least impacted categories ([Fig. 2](#f2-bbi-8-2014-045){ref-type="fig"}). Among the top metabolism subcategories affected by SCE, there was an overall inhibition of vitamin B6 metabolism, nicotinate and nicotinamide metabolism (metabolism of cofactors and vitamins), and arginine and proline metabolism (amino acid metabolism) ([Fig. 3](#f3-bbi-8-2014-045){ref-type="fig"}). Biosynthesis of unsaturated fatty acids (lipid metabolism), tyrosine metabolism, tryptophan metabolism, and drug metabolism--- cytochrome P450 also were among the top 50 inhibited metabolism subcategories ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: KEGG Liver sheet). The analysis further uncovered that steroid hormone biosynthesis (lipid metabolism), pentose inter-conversion (carbohydrate metabolism), glycosaminoglycan biosynthesis-- keratan sulfate (glycan biosynthesis and metabolism), and oxidative phosphorylation (energy metabolism) were the most activated subcategories ([Fig. 3](#f3-bbi-8-2014-045){ref-type="fig"}; [Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: KEGG Liver sheet).

Among the top subcategories within hepatic organismal system that were highly-impacted and activated with SCE were complement and coagulation cascades and chemokine signaling pathway (immune system), aldosterone-regulated sodium reabsorption (excretory system), and PPAR signaling pathway (endocrine system) ([Fig. 3](#f3-bbi-8-2014-045){ref-type="fig"}). Another activated subcategory with a role in the immune response was cytokine-cytokine receptor interaction within the environmental information processing category ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: KEGG Liver sheet). Within cellular processes, the most induced pathways included regulation of autophagy, lysosome and endocytosis (transport and catabolism), and apoptosis (cellular growth and death) ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: KEGG Liver sheet). Within the genetic information processing category, transcription, translational and protein export were the most activated and the SNARE interactions in vesicular transport was the most inhibited pathway ([Fig. 3](#f3-bbi-8-2014-045){ref-type="fig"}). Subclinical endometritis also was associated with induction of calcium signaling pathway, GnRH signaling pathway, and hedgehog signaling pathway among the top 50 subcategories ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: KEGG Liver sheet).

### Adipose

Functional analysis of the adipose microarray data revealed that metabolism, genetic information processing, and organismal system categories were the most impacted; whereas, cellular processes and environmental information processing were the least impacted categories ([Fig. 4](#f4-bbi-8-2014-045){ref-type="fig"}). Within the metabolism category, the most activated terms in the top 20 subcategories affected ([Fig. 5](#f5-bbi-8-2014-045){ref-type="fig"}) include nicotinate and nicotinamide metabolism (metabolism of cofactors and vitamins), pentose and glucuronate interconversions, starch and sucrose metabolism, ascorbate and aldarate metabolism (carbohydrate metabolism), amino sugar and nucleotide sugar metabolism, and oxidative phosphorylation (energy metabolism) ([Fig. 5](#f5-bbi-8-2014-045){ref-type="fig"}). The DIA also uncovered an inhibition of fructose and mannose metabolism among the top 20 affected subcategories ([Fig. 5](#f5-bbi-8-2014-045){ref-type="fig"}).

In addition, galactose metabolism (carbohydrate metabolism), cysteine and methionine metabolism, (amino acid metabolism), glycosaminoglycan biosynthesis---keratan sulfate, N-glycan biosynthesis, and glycosphingolipid biosynthesis--- lacto and neolacto series (Glycan biosynthesis and metabolism) were among the top 50 metabolism subcategories affected ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: KEGG Adipose sheet). Within the top 20 genetic information processing subcategories affected, the RNA degradation and basal transcription factor were the most impacted and activated, while RNA polymerase, protein export and sulfur-relay system were the most impacted and inhibited pathways ([Fig. 5](#f5-bbi-8-2014-045){ref-type="fig"}).

Among the top 20 affected subcategories, the peroxisome (cellular process) was the second most affected and, along with spliceosome, was overall activated ([Fig. 5](#f5-bbi-8-2014-045){ref-type="fig"}). Within adipose organismal system and among the top 50 affected subcategories the most impacted and activated pathways include T cell and B cell receptors signaling and Fc gamma R-mediated phagocytosis (immune system) ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: KEGG Adipose sheet); whereas, aldosterone-regulated sodium reabsorption (excretory system) and circadian rhythm (environmental adaptation) were the most impacted and inhibited pathways among the top 20 affected subcategories ([Fig. 5](#f5-bbi-8-2014-045){ref-type="fig"}). Among the top 20 affected subcategories, extracellular matrix (ECM)-receptor interaction (signaling and molecular interaction) was overall activated ([Fig. 5](#f5-bbi-8-2014-045){ref-type="fig"}). Among the top 50 affected subcategories, SCE was associated with an overall activation of mTOR signaling and VEGF signaling ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: KEGG Adipose sheet).

Gene ontology (GO) functional categories affected by subclinical endometritis as uncovered by the DIA
-----------------------------------------------------------------------------------------------------

We used the DIA to uncover the impact and direction (flux) of the pathways within the terms obtained from DAVID ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: DAVID Liver Up and Down sheets) as it relates to GO Biological Process (GOTERM_BP_FAT), Molecular Function (GOTERM_MF_FAT), Cellular Components (GOTERM_CC_FAT), KEGG_PATHWAY, and SP_PIR_KEYWORDS. A cutoff of the mean plus 1 standard deviation was used to obtain the top impacted pathways in each term. Detailed results from DIA are reported in [supplementary file 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"} (Liver DIA sheet).

The functional enrichment analysis of GO biological process (GOTERM_BP_FAT) with DIA revealed that the top 10 most impacted and activated pathways in this category were biosynthesis and production of interleukin-2, response to progesterone stimulus, gas homeostasis, nitric oxide homeostasis, negative regulation of tyrosine phosphorylation of STAT protein, negative regulation of peptidyl-tyrosine phosphorylation, positive regulation of sequestering of triglyceride, post-embryonic body morphogenesis, and vitamin D metabolic process ([Fig. 6](#f6-bbi-8-2014-045){ref-type="fig"}; [Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver DIA sheet). Other pathways among the top 20 with important roles in metabolism included positive regulation of lipid storage, negative regulation of nitric oxide biosynthetic process, negative regulation of JAK-STAT cascade, and positive regulation of lipid storage ([Fig. 6](#f6-bbi-8-2014-045){ref-type="fig"}; [Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver DIA sheet).

The functional enrichment analysis of GO cellular component (GOTERM_CC_FAT) with DIA revealed that the top 10 most impacted and activated pathways by SCE in this category were autophagic vacuole membrane, fibrinogen complex, smooth endoplasmic reticulum, perikaryon, integral to membrane of membrane fraction, very-low-density lipoprotein particle, triglyceride-rich lipoprotein particle, proton-transporting ATP synthase complex, coupling factor F(o), high-density lipoprotein particle, and autophagic vacuole ([Fig. 6](#f6-bbi-8-2014-045){ref-type="fig"}; [Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver DIA sheet).

The functional enrichment analysis of GO molecular functions (GOTERM_MF_FAT) with DIA revealed that the top 10 most impacted and activated pathways by SCE in this category were nitric-oxide synthase binding, interleukin-1 receptor activity, GABA receptor binding, cholesterol monooxygenase (side-chain-cleaving) activity, prenylcysteine oxidase activity, interleukin-1 binding, L-xylulose reductase (NADP+) activity, formate transmembrane transporter activity, N-acylneuraminate cytidylyltransferase activity, and adenosylmetathionine decarboxylase activity ([Fig. 6](#f6-bbi-8-2014-045){ref-type="fig"}; [Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: liver DIA sheet).

### Adipose

Among the relevant GO biological process (GOT-ERM_BP_FAT) that were among the top 20 most impacted and activated pathways in this category were positive regulation of activin receptor signaling pathway, muscarinic acetylcholine receptor signaling pathway, long-chain fatty acid transport, and negative regulation of myoblast differentiation ([Fig. 6](#f6-bbi-8-2014-045){ref-type="fig"}; [Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Adipose DIA sheet). Although with a much lower impact, defense response to virus, neuroprotection, and calcium-dependent cell-cell adhesion were among the top 50 pathways and were inhibited ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Adipose DIA sheet). Among the top 10 most impacted and activated terms within cellular components (GOT-ERM_CC_FAT) were mitochondrial crista, transcription factor TFIIE complex, collagen type I, peroxisome, and lipid particle ([Fig. 6](#f6-bbi-8-2014-045){ref-type="fig"}; [Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Adipose DIA Sheet).

Within the molecular function (GOTERM_MF-FAT) category, among the top ten impacted pathways were NAD+diphosphatase activity and nucleotide diphosphatase activity which were activated ([Fig. 6](#f6-bbi-8-2014-045){ref-type="fig"}). In contrast, carbonate dehydratase activity was among the top 10 inhibited pathways, and retinoic acid receptor activity among the top 25 inhibited pathways.

Discussion
==========

Despite the marked differences in uterine swab PMN percentage, neither the BCS nor the blood concentrations of most biomarkers differed between healthy cows and those with SCE. However, those responses contrast with the lower milk production ([Fig. 1](#f1-bbi-8-2014-045){ref-type="fig"}) during the first three weeks of lactation, numerically greater plasma globulin concentration, and changes in gene expression in the subcutaneous adipose and liver tissue of cows with SCE. The bioinformatics analyses of affected genes revealed alterations in several pathways encompassing nutrient metabolism, cell signaling, inflammation, and oxidative stress, among others. Furthermore, the up-regulation of total *GHR* without a change in *IGF1* expression in liver suggested a further or more persistent uncoupling of the somatotropic axis in the SCE cows. Molecular data from this study are among the first to demonstrate a response in peripheral tissues to the onset of subclinical inflammation of the uterine tissue.

Body condition score (BCS), blood metabolites, and subclinical endometritis
---------------------------------------------------------------------------

In the current study, despite the small number of animals, the lack of a health status effect on BCS pre or postpartum suggests that loss of BCS due to onset of lactation, per se, is not a major risk factor for developing SCE. The lack of differences in concentration of NEFA in the present study agrees with previous similar studies.[@b16-bbi-8-2014-045],[@b45-bbi-8-2014-045],[@b84-bbi-8-2014-045],[@b85-bbi-8-2014-045] Overall, the observations from the present study seem to confirm the suggestion of Burke et al. that energy status per se is not a risk factor for SCE.[@b16-bbi-8-2014-045]

Serum globulin concentrations can provide an indication of an animal's humoral immune status or response;[@b35-bbi-8-2014-045] a high concentration of globulin and globulin: albumin ratio is suggestive of lymphocyte proliferation and greater levels of circulating antibodies.[@b35-bbi-8-2014-045] The numerically greater concentration of globulin ([Table 1](#t1-bbi-8-2014-045){ref-type="table"}) is in accordance with previous data from cows with endometritis,[@b16-bbi-8-2014-045],[@b36-bbi-8-2014-045] and is indicative of an activation of adaptive immune responses.

The lack of clear differences in concentrations of Mg, AST, and GDH between groups is opposite to previous reports of lower Mg concentrations in cows with liver dysfunction;[@b37-bbi-8-2014-045] whereas, Burke et al.[@b16-bbi-8-2014-045] reported greater concentrations of AST and GDH and lower Mg concentration in cows with SCE. Therefore, in the current study the onset of SCE did not seem to cause a severe impairment in liver function and likely explains the similar BCS after calving and the small difference in milk production between groups.

Molecular links between adipose and liver tissue during subclinical endometritis
--------------------------------------------------------------------------------

Subclinical endometritis induced a state of local inflammation and oxidative stress in adipose tissue as indicated by the greater expression of *CCL2* and *IL6* and the lower expression of metabolic-related genes such as *PLIN2, SLC2A4*, and *IRS1* ([Table 5](#t5-bbi-8-2014-045){ref-type="table"}). At the molecular level such changes would have resulted in sustained adipose tissue lipolysis leading to activation of long-chain fatty acid transport ([Fig. 6](#f6-bbi-8-2014-045){ref-type="fig"}), either for efflux into the blood or as a means to recycle fatty acids within the adipose tissue.[@b38-bbi-8-2014-045] Despite the lack of statistical difference in the expression of lipogenic genes (*SCD*, *FASN*) and transcription regulators (*SREBF1*), the lack of difference in blood NEFA could be taken as indication of greater recycling of long-chain fatty acids within adipose tissue. Alternatively, the lack of increase in blood NEFA of cows with SCE resulted from metabolism in liver and/or mammary gland to prevent excessive buildup in the circulation.

The greater hepatic expression of *RXRA* and the overall activation and high impact of the PPAR signaling pathway ([Fig. 3](#f3-bbi-8-2014-045){ref-type="fig"}) in SCE cows provides some evidence of greater NEFA utilization in liver despite the fact that expression of genes associated with fatty acid oxidation (*ACOX1*, *CPT1A*) and ketogenesis (*HMGCS2*) did not differ ([Table 4](#t4-bbi-8-2014-045){ref-type="table"}). Together with most of the blood data, eg the lack of change in AST and GDH, which are markers of liver function,[@b18-bbi-8-2014-045] it appears that SCE did not cause long-term negative effects on metabolic activity of liver.

The tumor suppressor TP53 is a transcription factor that preserves genomic stability and prevents oncogenesis. Various genotoxic stresses such as DNA damage, oxidative stress, hypoxia, and heat shock can activate TP53, causing changes in the expression of its target genes.[@b39-bbi-8-2014-045] In non-ruminants, in addition to maintaining genomic integrity, TP53 can induce proinflammatory cytokines in adipose and cause insulin resistance.[@b40-bbi-8-2014-045],[@b41-bbi-8-2014-045] In dairy cows, negative energy balance and inflammatory conditions were reported to induce TP53 expression and its signaling in various tissues, eg liver, adipose, and spleen.[@b30-bbi-8-2014-045],[@b86-bbi-8-2014-045]--[@b88-bbi-8-2014-045] In addition to eliciting effects on other genes, TP53 can affect glucose metabolism in insulin-sensitive tissues by repressing the expression of *SLC2A4*,[@b42-bbi-8-2014-045] which is the insulin-sensitive glucose transporter. The up-regulation of *TP*53 expression ([Table 5](#t5-bbi-8-2014-045){ref-type="table"}) in adipose tissue and the lower milk production in cows with SCE suggests that the availability of glucose for the immune system might have increased at least in part by limiting the intracellular glucose transport via direct repression of glucose uptake ([Table 5](#t5-bbi-8-2014-045){ref-type="table"}, [Fig. 7](#f7-bbi-8-2014-045){ref-type="fig"}).[@b42-bbi-8-2014-045],[@b43-bbi-8-2014-045] The expression of *SLC2A4* in dairy cattle adipose tissue can be up-regulated by feeding diets with greater non-structural carbohydrate, hence, allowing for greater glucose uptake for lipogenesis.[@b44-bbi-8-2014-045]

A recent study also did not find differences in glucose concentration between healthy and endometritic cows.[@b16-bbi-8-2014-045] In contrast, Senosy et al. reported that low blood glucose is a risk factor in cows diagnosed with endometritis.[@b45-bbi-8-2014-045] The difference in the response of glucose to endometritis among different studies could be due to the time of sampling, eg, Senosy et al.[@b45-bbi-8-2014-045] observed differences in glucose concentration at 28 days postpartum in cows diagnosed with endometritis at 42 days postpartum but in the present study the SCE was evaluated at 22 or 25 days postpartum.

Subclinical endometritis and cholesterol metabolism
---------------------------------------------------

Cholesterol and its derivatives are essential for vital functions in the body; the intracellular quantity of cholesterol and its distribution to subcellular compartments (eg, ER, Golgi) are two key regulatory points that help maintain an optimal concentration of cholesterol at the cellular level.[@b46-bbi-8-2014-045] As in other mammals, the cow achieves cholesterol homeostasis through the endogenous synthesis of cholesterol and regulating its turn over via lipoprotein metabolism; hepatic gene expression is an important part of the control mechanisms involved in this process.[@b89-bbi-8-2014-045],[@b90-bbi-8-2014-045]

Transcriptomic data from liver in the present study indicate that SCE induced intracellular cholesterol homeostasis and transport, at least in part, by up-regulating the expression of *CAV1* and *NPC2* ([Table 2](#t2-bbi-8-2014-045){ref-type="table"}); both genes are involved in intracellular cholesterol flux and have important roles in the regulation of intracellular cholesterol homeostasis.[@b46-bbi-8-2014-045]--[@b48-bbi-8-2014-045] Sub-clinical endometritis increased hepatic *RXRA* ([Table 4](#t4-bbi-8-2014-045){ref-type="table"}), which in addition to enhancing long-chain fatty acid oxidation leads to an increase in *CAV1* expression (cholesterol homeostasis).[@b49-bbi-8-2014-045] Similar to a previous study,[@b50-bbi-8-2014-045] the overall activation of apoptosis ([Fig. 3](#f3-bbi-8-2014-045){ref-type="fig"}) in liver also could have partly mediated the observed change in cholesterol homeostasis and the up-regulation of *CAV1*. Although we did not measure it in the study, such response might have increased hepatic lipid accumulation.

Cholesterol is the precursor for steroid hormone synthesis, and the process is initiated by cleavage of cholesterol to produce pregnenolone. The observed induction in cholesterol monooxygenase activity (the key enzyme) and MAPK activity ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver DIA sheet) in cows with SCE are noteworthy. The MAPK proteins are known to be involved in the regulation of steroid production by different mechanisms; among those, the induction of expression of *CYP11A1* is very prominent.[@b51-bbi-8-2014-045] Subclinical endometritis induced hepatic *CYP11A1* ([Table 2](#t2-bbi-8-2014-045){ref-type="table"}), which catalyzes the conversion of cholesterol to pregnenolone, the first and rate-limiting step in the synthesis of the steroid hormones. Therefore, MAPK appears to play a role in regulating cholesterol homeostasis in liver during endometritis.[@b52-bbi-8-2014-045] The expression data support observations from a recent study, which reported lower cholesterol at wk 4 postpartum in cows diagnosed with endometritis at wk 5.[@b45-bbi-8-2014-045] Taking into account that samples in our study were harvested on day 29 postpartum, we speculate that the decrease in cholesterol at wk 4 in the study of Senosy et al.[@b45-bbi-8-2014-045] could have been associated with greater cleavage of cholesterol to steroids.

Molecular signatures of inflammation
------------------------------------

The activation of local and systemic host defense mechanisms requires interactions between numerous types of immune cells and inflammatory mediators, such as nitric oxide (NO), prostaglandins, and cytokines.[@b53-bbi-8-2014-045] Signal transduction occurs via several intracellular pathways, including the Janus kinase (JAK)--STAT pathway, the phosphoinositide 3-kinase (PI3K)--AKT pathway and the MAPK pathway.[@b54-bbi-8-2014-045] Moreover, the complement and coagulation cascades are the first line of defense that helps the host against injurious stimuli and inflammation.[@b91-bbi-8-2014-045],[@b92-bbi-8-2014-045]

During pathophysiological situations, the activation of these cascades (both complement and coagulation cascades) occurs simultaneously and is intended to act locally; however, systemic activation of these pathways has been reported in situations when the relevant control mechanism at the site of infection fail to respond.[@b55-bbi-8-2014-045] Therefore it is speculated that the increase in the hepatic expression of genes associated with complement and coagulation cascades in SCE cows ([Fig. 3](#f3-bbi-8-2014-045){ref-type="fig"}; [Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver DIA) could have been associated with a failure of control mechanisms within the endometrium. This idea seems to be supported by previous data demonstrating a decrease in PMN function[@b5-bbi-8-2014-045] and potential modifications of both the innate and adaptive immune systems in cows with endometritis.[@b12-bbi-8-2014-045],[@b13-bbi-8-2014-045]

Cytokines play an important role in a wide range of reproductive-related processes via regulation of a complex metabolic network.[@b56-bbi-8-2014-045] The activation of pathways leading to biosynthesis of IL-2 and activity of IL-1 in cows with SCE indicates an activation of both innate and adaptive immune systems.[@b54-bbi-8-2014-045],[@b57-bbi-8-2014-045] The decrease in hepatic expression of chemokine (C-C motif) receptor 4 (*CCR*4) ([Table 2](#t2-bbi-8-2014-045){ref-type="table"}) with SCE could have had a major contribution to the activation of the innate immune system.[@b58-bbi-8-2014-045] For instance, in CCR4^−/−^ mice receiving LPS,[@b58-bbi-8-2014-045] there was a marked induction of the JNK and p38 MAPK pathways, which we also observed in liver ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver DIA).

Nitric oxide is an inflammatory mediator that among other effects mediates cytoimmunity and inflammation toxicity.[@b59-bbi-8-2014-045] An increase of NO has been reported with endometritis in both cows[@b59-bbi-8-2014-045] and mares.[@b60-bbi-8-2014-045] Although we did not measure the concentration of NO in tissue or blood, the activation of pathways associated with hepatic NO homeostasis and negative regulation of nitric oxide biosynthetic process ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver DIA) indicates changes in NO concentrations in SCE cows. As such, a local increase in NO within liver tissue could, at least in part, be associated with the changes in the expression of inflammatory genes.

Haptoglobin is an acute-phase protein primarily synthesized in the liver that accomplishes its function by acting as an antioxidant, anti-inflammatory agent, bacteriostat, and by regulating the maturation and activity of immune cells.[@b61-bbi-8-2014-045] The increase in *HP* expression in liver ([Table 4](#t4-bbi-8-2014-045){ref-type="table"}) from cows with SCE agrees with previous work reporting greater serum concentration of HP in Holstein cows with acute puerperal metritis.[@b62-bbi-8-2014-045] A greater concentration of HP also was observed in cows with retained fetal membranes, which is one of the key risk factors associated with uterine infection.[@b63-bbi-8-2014-045] From a mechanistic standpoint, the numerical up-regulation of *SOCS2* (1.5-fold) and *STAT3* (\~2-fold) ([Table 4](#t4-bbi-8-2014-045){ref-type="table"}) not only suggests an augmentation of cytokine signaling[@b64-bbi-8-2014-045] with SCE but also a potential impairment of growth hormone signaling.[@b65-bbi-8-2014-045]

The immune responsive role of adipose depots has been studied previously,[@b30-bbi-8-2014-045],[@b66-bbi-8-2014-045] and data from the present study support this role, eg there was activation of B cell receptor signaling, cytokine-cytokine receptor interaction, and T cell receptor signaling pathways in subcutaneous adipose from cows with SCE. A novel response in this study was the induction of the mTOR signaling pathway in cows with SCE ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Adipose DIA); mTOR is a large molecular-weight protein that mediates intracellular signaling related to cell growth, proliferation, and differentiation.[@b67-bbi-8-2014-045],[@b68-bbi-8-2014-045] In non-ruminants the increase in mTOR signaling pathway in adipocytes is mediated by PI3K-ATK signaling, which is activated by cytokines and ECM ([Fig. 8](#f8-bbi-8-2014-045){ref-type="fig"}).[@b69-bbi-8-2014-045],[@b70-bbi-8-2014-045]

In addition to other regulatory mechanisms, PI3K can also be activated by insulin through IRS1/2(Insulin receptor substrate-1/2); PI3K then leads to activation of mTOR via Akt.[@b71-bbi-8-2014-045] In adipose tissue, *AKT2* is the predominant isoform of Akt;[@b72-bbi-8-2014-045] the down-regulation of *IRS1* and *SLC2A4* (insulin-induced glucose transporter) indicates that the up-regulation of *AKT2* ([Table 3](#t3-bbi-8-2014-045){ref-type="table"}) might have been mediated by PI3 K via the activation of cytokines and ECM rather than insulin signaling ([Fig. 8](#f8-bbi-8-2014-045){ref-type="fig"}). Increased signaling through AKT2 then could have regulated mTOR signaling by phosphorylating the *AKT1S1* (PPAS40) ([Table 3](#t3-bbi-8-2014-045){ref-type="table"}). Moreover, the tendency for greater expression of *STAT3* in adipose tissue ([Table 5](#t5-bbi-8-2014-045){ref-type="table"}) suggests that mTOR might have elicited its effect by phosphorylation at Ser727.[@b93-bbi-8-2014-045],[@b94-bbi-8-2014-045] Following phosphorylation, STAT protein translocates to the nucleus to regulate transcription or activate the transcription of target genes associated with cell-cycle progression and apoptosis. As a result, STAT can promote cellular transformation as well as abnormal cell proliferation.[@b95-bbi-8-2014-045],[@b96-bbi-8-2014-045] In addition to important roles in cytokine signaling pathways, STAT3 has been reported to contribute to the phenotypic variation in embryonic survival in cattle.[@b97-bbi-8-2014-045],[@b98-bbi-8-2014-045]

Molecular adaptations in Vitamin B3 and B6 metabolism
-----------------------------------------------------

In the present study, an activation of genes coding for enzymes associated with oxidative phosphorylation in both liver (eg, *ATP5A1*) and adipose (eg, *ATP6V1B2, COX6B2, NDUFS6*) ([Tables 2](#t2-bbi-8-2014-045){ref-type="table"} and [3](#t3-bbi-8-2014-045){ref-type="table"}) was observed. As precursors of the coenzymes nicotinamide-adenine dinucleotide (NAD+) and nicotinamide-adenine dinucleotide phosphate (NADP+), both nicotinic acid (anionic form: nicotinate) and nicotinamide (amide derivative of nicotinic acid) are essential for organisms.[@b73-bbi-8-2014-045] Nicotinic acid and nicotinamide are often grouped together under the generic term niacin, and are also known as vitamin B3.[@b74-bbi-8-2014-045]

The reduction in flux of nicotinate and nicotinamide metabolism in liver did not seem to alter mitochondrial respiration per se because expression of genes associated with fatty acid oxidation (*CPT1A*, *ACOX1*) did not change. It could be possible that this reduction in flux in SCE cows reflected a state of oxidative stress (up-regulated *SOD2* and *GPX1*; [Table 4](#t4-bbi-8-2014-045){ref-type="table"}), at least in part, because of a decrease in niacin availability.[@b75-bbi-8-2014-045] In contrast, the induction of this pathway in adipose tissue suggests the tissue might have an inherently greater ability to counteract oxidative stress compared with liver, potentially as a function of niacin accumulation. Additionally, cows in the present study were fed predominately forage diets, with potentially greater availability of niacin.[@b76-bbi-8-2014-045] The amino acid tryptophan is the sole substrate for *de novo* NAD+ and NADP+ synthesis in the absence of nicotinamide or nicotinic acid. All species are able to synthesize niacin from tryptophan and quinolinate.[@b73-bbi-8-2014-045] The decrease in tryptophan metabolism ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver KEGG sheet) in cows with SCE is additional evidence of a state of oxidative stress in the liver.

Because of its integral involvement in the synthesis of nucleic acid, and consequently in mRNA and protein synthesis, vitamin B6 influences acquired and humoral immunity, and the production of cytokines and inflammatory mediators.[@b77-bbi-8-2014-045] The vitamin B3 metabolite N-methylnicotinamide may exert anti-inflammatory and anti-oxidative stress effects.[@b78-bbi-8-2014-045] The observed inhibition of vitamin B3 and B6 metabolism was associated with activation of cytokine and proinflammatory cytokine production ([Suppl 2](#s1-bbi-8-2014-045){ref-type="supplementary-material"}: Liver DIA sheet) and oxidative stress (*SOD2* and *GPX1* up-regulation; [Table 4](#t4-bbi-8-2014-045){ref-type="table"}). In contrast, the activation of vitamin B3 (nicotinamide) metabolism ([Fig. 5](#f5-bbi-8-2014-045){ref-type="fig"}) in adipose tissue may have served a protective role against oxidative stress (*SOD2* up-regulation) ([Table 5](#t5-bbi-8-2014-045){ref-type="table"}) to protect cells against reactive oxygen species.[@b79-bbi-8-2014-045]

Intracellular energy status and oxidative stress
------------------------------------------------

Mitochondria are responsible for \~90% of oxygen consumption and ATP production;[@b80-bbi-8-2014-045] however, they are also major sources of intracellular reactive oxygen metabolites (ROM).[@b81-bbi-8-2014-045] In dairy cows, excessive production of ROM may lead to oxidative stress when the body antioxidant defenses are insufficient, which is a major risk factor associated with endometritis.[@b82-bbi-8-2014-045]

The protein ATP6V1B2, which transports H+ across the membrane of intracellular organelles, also is a component of the B2 subunit of the H+ transporting AT-Pase (VATPase).[@b99-bbi-8-2014-045],[@b100-bbi-8-2014-045] Previous studies reported that an increase in V-ATPase led to the accumulation of ROM.[@b100-bbi-8-2014-045],[@b101-bbi-8-2014-045] Therefore, it could be possible that in the present study the evident changes enhanced oxidative phosphorylation and ROM production, which coupled with the greater hepatic expression of *SOD2* and *GPX1* ([Table 4](#t4-bbi-8-2014-045){ref-type="table"}), suggests that SCE can enhance the oxidative stress status of peripheral tissues.

Conclusions
===========

The local uterine inflammation appears to induce a marked inflammatory response at the level of liver, whereas in adipose, there was a more pronounced response in oxidative stress and apoptosis coupled with impaired insulin signaling. The lack of change in BCS, plasma NEFA concentration, and gene expression data associated with lipolysis and lipogenesis provides additional evidence that energy status of the cow is not a primary risk factor for SCE. Despite the observed changes at the molecular level, there were no evident systemic long-term negative effects on liver function.
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![Body condition score and daily milk yield in healthy cows (no uterine infection, NUI) and cows with subclinical endometritis (SCE). Body condition score is reported on a 1--10 scale, where 1 is emaciated and 10 obese.[@b24-bbi-8-2014-045],[@b83-bbi-8-2014-045]\
**Notes:** The bar associated with each mean denotes the standard error of the mean.](bbi-8-2014-045f1){#f1-bbi-8-2014-045}

![Impact and flux of main KEGG pathways categories and sub-categories affected by subclinical endometritis constructed from liver differentially expressed genes (DEG) as calculated by the Dynamic Impact Approach. Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) and the direction of the impact (or flux; green bars expanding left denote inhibition and red bars expanding right denote activation) of DEG on the categories and subcategories.](bbi-8-2014-045f2){#f2-bbi-8-2014-045}

![Impact and flux of the top 20 KEGG pathways affected by subclinical endometritis in liver tissue uncovered by the Dynamic Impact Approach (DIA). Reported are the total impact (blue horizontal bars; larger the bars higher the impact) and the direction of the impact (or flux; green shade denotes inhibition and red shade denotes activation).](bbi-8-2014-045f3){#f3-bbi-8-2014-045}

![Impact and flux of main KEGG pathways categories and sub-categories affected by subclinical endometritis constructed from adipose differentially expressed genes (DEG) as calculated by the Dynamic Impact Approach. Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) and the direction of the impact (or flux; green bars expanding left denote inhibition and red bars expanding right denote activation) of DEG on the categories and subcategories.](bbi-8-2014-045f4){#f4-bbi-8-2014-045}

![Impact and flux of top 20 KEGG pathways affected by subclinical endometritis in subcutaneous adipose tissue uncovered by the Dynamic Impact Approach (DIA). Reported are the total impact (blue horizontal bars; larger the bars higher the impact) and the direction of the impact (or flux; green shade denotes inhibition and red shade denotes activation).](bbi-8-2014-045f5){#f5-bbi-8-2014-045}

![Most up- and down-regulated pathways due to subclinical endometritis in the Biological process (BP), Cellular components (CC) and Molecular processes (MP) GO categories uncovered by DIA using differentially expressed genes in liver and adipose tissue. Reported are the impact (blue horizontal bars; the larger the bar the higher the impact) and the direction of the impact (or flux; green shade denotes inhibition and red shade denotes activation).](bbi-8-2014-045f6){#f6-bbi-8-2014-045}

![Insulin signaling KEGG pathway in adipose tissue. Green shade denotes down-regulation while red/yellow tones denote up-regulation of genes in SCE cows. The genes enclosed in a colored box were not present on the microarray platform but were analyzed by qPCR.](bbi-8-2014-045f7){#f7-bbi-8-2014-045}

![PI3K-AKT signaling KEGG pathway in adipose tissue. Green shade denotes down-regulation while red/yellow tones denote up-regulation of genes in SCE cows. The genes enclosed in a colored box were not present on the microarray platform but were analyzed by qPCR.](bbi-8-2014-045f8){#f8-bbi-8-2014-045}

###### 

Plasma metabolite concentration on the day of slaughter in healthy cows (no uterine infection, NUI) or cows with subclinical endometritis (SCE).

                                                                GROUP                   
  ------------------------------------------------------------- ------- -------- ------ ------
                                                                                        
  NEFA, mmol/L                                                  1.50    1.69     0.18   0.46
                                                                                        
  Protein                                                       82.1    77.1     2.8    0.23
                                                                                        
  Albumin, g/L                                                  36.8    37.5     25.8   0.75
                                                                                        
  Globulin, g/L[1](#tfn1-bbi-8-2014-045){ref-type="table-fn"}   45.3    39.6     2.2    0.11
                                                                                        
  Albumin/Globulin ratio                                        0.83    0.95     0.06   0.23
                                                                                        
  Mg, mmol/L                                                    0.66    0.70     10.6   0.70
                                                                                        
  GDH, IU/L[2](#tfn2-bbi-8-2014-045){ref-type="table-fn"}       24.3    28.3     5.5    0.62
                                                                                        
  AST, IU/L[3](#tfn3-bbi-8-2014-045){ref-type="table-fn"}       78.5    8 7. 5   4.6    0.20

**Notes:**

Globulin is calculated when albumin is subtracted from total protein.

GDH = glutamate dehydrogenase.

AST = aspartate aminotransferase.

###### 

List of all genes that were differentially expressed in liver tissue due to subclinical endometritis.[1](#tfn4-bbi-8-2014-045){ref-type="table-fn"}

  GENE ID     SYMBOL        EXPRESSION RATIO SCE/NUI   *P* =   GENE ID     SYMBOL        EXPRESSION RATIO SCE/NUI   *P* =
  ----------- ------------- -------------------------- ------- ----------- ------------- -------------------------- -------
  281358      *NPR3*        0.43                       0.001   --          *KIAA1639*    1.54                       0.05
  782932      *C2orf53*     0.46                       0.04    282578      *ATP5A1*      1.54                       0.03
  541142      *LANCL2*      0.48                       0.01    526937      *DCXR*        1.54                       0.001
  338074      *AOX1*        0.52                       0.03    504664      *NRBP2*       1.54                       0.001
  286794      *MMP7*        0.52                       0.04    534579      *TFDP1*       1.55                       0.01
  281938      *MYOD1*       0.52                       0.001   534799      *TOP1*        1.55                       0.001
  538785      *STAMBPL1*    0.53                       0.03    514465      *SMAP1L*      1.56                       0.001
  522346      *LOC522346*   0.55                       0.03    767942      *GRN*         1.56                       0.001
  616425      *SUPT4H1*     0.55                       0.01    280815      *NPC2*        1.56                       0.01
  524334      *L3MBTL3*     0.55                       0.001   538975      *CNN3*        1.57                       0.05
  282092      *TIMP1*       0.55                       0.04    511852      *ASB11*       1.57                       0.03
  530184      *SSBP3*       0.56                       0.04    525619      *LOC525619*   1.57                       0.02
  615833      *IFITM3*      0.56                       0.04    535362      *GRM7*        1.58                       0.02
  286822      *CKM*         0.58                       0.02    514514      *CELSR3*      1.58                       0.01
  --          *CN437645*    0.59                       0.01    444859      *ST3GAL3*     1.58                       0.03
  768316      *NRBF2*       0.60                       0.03    535258      *HSPC148*     1.58                       0.001
  338074      *LOC618565*   0.61                       0.05    533483      *CMAS*        1.59                       0.03
  282684      *CSNK1A1*     0.61                       0.05    282385      *TMSB10*      1.60                       0.05
  780809      *VTI1B*       0.61                       0.01    522795      *KLF10*       1.61                       0.04
  282100      *TRPC1*       0.61                       0.001   530352      *SLC39A1*     1.63                       0.01
  535232      *LOC535232*   0.62                       0.01    783871      *PI3*         1.64                       0.01
  616676      *GALM*        0.62                       0.03    444874      *UBC*         1.64                       0.02
  524743      *LOC524743*   0.62                       0.01    614936      *ILF3*        1.65                       0.03
  --          *BF043596*    0.62                       0.001   536863      *MPDZ*        1.65                       0.04
  574056      *TNFRSF8*     0.63                       0.02    534366      *C6orf62*     1.65                       0.03
  100139141   *SHROOM3*     0.63                       0.01    281040      *CAV1*        1.66                       0.001
  --          *CN438887*    0.63                       0.01    286883      *MAP*2*K*6    1.66                       0.02
  --          *CN435533*    0.64                       0.01    100125835   *PCYOX1*      1.67                       0.01
  507060      *WBP2*        0.64                       0.01    280997      *AMD1*        1.68                       0.04
  507503      *THAP4*       0.64                       0.03    282711      *EPAS1*       1.70                       0.01
  408019      *CCR4*        0.64                       0.03    282146      *ATP2B4*      1.72                       0.01
  512648      *ELL3*        0.65                       0.01    614280      *C7orf23*     1.73                       0.001
  514788      *ACOT7*       0.65                       0.05    530076      *GC*          1.76                       0.03
  508167      *LOC508167*   0.66                       0.04    327715      *GABARAP*     1.76                       0.001
  319095      *ADCYAP1R1*   0.66                       0.01    510102      *RARRES1*     1.78                       0.001
  --          *LOC727737*   1.50                       0.03    767925      *RPL13A*      1.80                       0.02
  505031      *C6orf49*     1.51                       0.001   100298683   *FAM*43*B*    1.85                       0.02
  533894      *LRP1*        1.51                       0.001   415113      *HSPA5*       1.91                       0.03
  511425      *LOC511425*   1.51                       0.01    618041      *APOC4*       1.95                       0.001
  504506      *RNPS1*       1.51                       0.001   280988      *AHSG*        2.01                       0.04
  506149      *C22orf32*    1.51                       0.03    534961      *C1QA*        2.07                       0.001
  508722      *RBM39*       1.52                       0.04    768005      *Slc9a3r2*    2.11                       0.001
  512841      *Crk*         1.52                       0.01    540176      *ATP5G3*      2.15                       0.001
  --          *BF045974*    1.53                       0.001   281760      *FABP5*       2.31                       0.02
  --          *SLC2A3P1*    1.53                       0.01    510522      *FGB*         2.42                       0.01
  613930      *MGC128212*   1.54                       0.03    513055      *RGS2*        2.52                       0.001
  540007      *FAAH*        1.54                       0.001   539334      *IL1RAP*      2.54                       0.001
  507107      *SLC3A2*      1.54                       0.001   338048      *CYP11A1*     2.65                       0.04

**Notes:**

SCE = subclinical uterine infection (endometritis). NUI = no uterine infection.

###### 

List of all genes that were differentially expressed in subcutaneous adipose tissue due to subclinical endometritis.[1](#tfn5-bbi-8-2014-045){ref-type="table-fn"}

  GENE ID   SYMBOL            EXPRESSION RATIO SCE/NUI   *P* =   GENE ID     SYMBOL             EXPRESSION RATIO SCE/NUI   *P* =
  --------- ----------------- -------------------------- ------- ----------- ------------------ -------------------------- -------
  326334    *CA11*            0.06                       0.001   100140537   *POLR3E*           0.65                       0.01
  506415    *RSAD2*           0.30                       0.01    281187      *GDF8*             0.65                       0.03
  527934    *CORO7*           0.32                       0.001   338079      *NDUFS7*           0.65                       0.01
  281127    *DSC1*            0.34                       0.04    100138153   *CNNM3*            0.65                       0.02
  --        *9430053O09Rik*   0.41                       0.02    281781      *B4GALT1*          0.65                       0.02
  515954    *HYI*             0.41                       0.01    514263      *TMEM39B*          0.65                       0.01
  513765    *TRABD*           0.43                       0.03    519163      *KLF16*            0.67                       0.05
  615833    *IFITM3*          0.43                       0.01    --          *SCRAMBLE2*        1.50                       0.04
  507525    *VTN*             0.44                       0.02    527491      *SLC38A1*          1.50                       0.001
  509430    *SRP72*           0.45                       0.01    530401      *LOC530401*        1.51                       0.01
  786644    *LOC786644*       0.46                       0.001   518675      *BZRAP1*           1.51                       0.03
  508527    *FAM44A*          0.46                       0.03    767924      *MST150*           1.51                       0.001
  280830    *IVL*             0.47                       0.01    507707      *TOMM70A*          1.51                       0.05
  531369    *TTF2*            0.47                       0.02    --          *LOC729867*        1.52                       0.04
  516232    *ZNF653*          0.48                       0.02    --          *CN441658*         1.52                       0.05
  527928    *UGT2A1*          0.48                       0.001   281564      *UGDH*             1.53                       0.01
  510377    *SP140*           0.49                       0.01    503554      *COX6B2*           1.53                       0.01
  529049    *MRC2*            0.49                       0.05    516762      *LOC516762*        1.53                       0.04
  --        *LOC512590*       0.50                       0.001   505738      *MCOLN1*           1.53                       0.01
  516866    *ALPK3*           0.51                       0.01    514957      *KIAA0020*         1.55                       0.001
  768005    *Slc9a3r2*        0.52                       0.03    509050      *C15orf40*         1.55                       0.01
  --        *BM363375*        0.52                       0.001   508935      *SYMPK*            1.55                       0.04
  527903    *LOC653968*       0.52                       0.03    282524      *SLC25A16*         1.55                       0.03
  614868    *KHK*             0.53                       0.01    613479      *MGC133516*        1.56                       0.02
  --        *C14orf73*        0.53                       0.02    281944      *NR2E3*            1.57                       0.01
  533984    *SUB1*            0.53                       0.03    538444      *SET*              1.59                       0.03
  --        *OAS1*            0.53                       0.01    540605      *CREM*             1.59                       0.04
  512972    *HMHA1*           0.54                       0.001   525040      *LOC525040*        1.60                       0.01
  541100    *PLEKHH3*         0.55                       0.001   281751      *EIF4E*            1.61                       0.05
  504889    *GMPPA*           0.56                       0.04    338082      *ATP6V1B2*         1.61                       0.03
  286850    *GNG12*           0.56                       0.02    536417      *SEMA3D*           1.62                       0.04
  --        *BF043373*        0.56                       0.04    613644      *CD99L2*           1.62                       0.001
  516456    *MVP*             0.56                       0.04    614521      *Rab35*            1.62                       0.03
  615501    *LOC615501*       0.56                       0.04    614583      *LOC614583*        1.62                       0.04
  514859    *AKT1S1*          0.57                       0.03    --          *CN438914*         1.63                       0.001
  532997    *AOF2*            0.57                       0.04    521854      *NID2*             1.64                       0.02
  615146    *SOCS6*           0.57                       0.03    --          *TC359671*         1.65                       0.001
  529131    *LOC529131*       0.58                       0.02    532209      *LOC532209*        1.65                       0.02
  521868    *PTPRH*           0.58                       0.05    505727      *NOV*              1.66                       0.04
  514291    *EMILIN2*         0.59                       0.02    524854      *THUMPD1*          1.66                       0.02
  534280    *RARA*            0.59                       0.03    531535      *MGC139383*        1.67                       0.001
  516318    *PER1*            0.59                       0.04    --          *CK394167*         1.74                       0.02
  536731    *LOC536731*       0.59                       0.001   507102      *SREBF2*           1.75                       0.02
  505328    *OSBPL2*          0.60                       0.001   450214      *CENPC1*           1.76                       0.01
  783452    *NRG2*            0.60                       0.05    534923      *AKT2*             1.76                       0.04
  513577    *LOC513577*       0.60                       0.01    768209      *5730406M06Rik*    1.77                       0.02
  512069    *MGC137476*       0.60                       0.02    529149      *MGC52110*         1.79                       0.04
  511254    *NRD1*            0.60                       0.03    540525      *GTF2E1*           1.79                       0.001
  522346    *LOC522346*       0.60                       0.02    504483      *BLMH*             1.79                       0.01
  327685    *ANXA6*           0.61                       0.02    280981      *ADFP*             1.80                       0.05
  507065    *RBM19*           0.61                       0.03    282188      *COL1A2*           1.80                       0.01
  513300    *SENP8*           0.61                       0.03    282484      *SLC34A2*          1.80                       0.02
  518833    *CYFIP2*          0.61                       0.02    782059      *SCYL2*            1.82                       0.01
  786191    *HIC1*            0.61                       0.001   780788      *ITGB1BP3*         1.85                       0.02
  282431    *PROKR2*          0.62                       0.03    617358      *ASB1*             1.85                       0.03
  --        *CN438353*        0.62                       0.001   540172      *MGC10433*         1.91                       0.04
  539675    *ZNF415*          0.62                       0.03    505889      *PPYR1*            1.94                       0.04
  --        *FLJ45422*        0.62                       0.04    281598      *ACVR2A*           1.97                       0.04
  532645    *MAN1A2*          0.62                       0.02    --          *NG010008B10D06*   1.98                       0.02
  280946    *TST*             0.62                       0.01    282127      *ZFP36*            2.01                       0.04
  511691    *LOC511691*       0.63                       0.02    539795      *ABHD3*            2.04                       0.001
  512308    *MMRN2*           0.63                       0.01    525795      *AGRN*             2.04                       0.02
  617894    *LOC617894*       0.63                       0.02    281490      *JARID1C*          2.06                       0.02
  --        *CR452857*        0.63                       0.01    --          *TC345541*         2.11                       0.01
  505884    *KLF6*            0.63                       0.01    327691      *NDUFS6*           3.32                       0.001
  534394    *NIP30*           0.63                       0.03    614759      *LSM3*             3.48                       0.001
  616482    *RANBP3*          0.63                       0.03    337916      *IRF2*             4.13                       0.001
  535203    *NTHL1*           0.63                       0.01    617720      *NUDT12*           4.41                       0.001
  --        *BF440371*        0.63                       0.02    --          *CR551628*         7.15                       0.001
  407996    *KRIT1*           0.64                       0.02                                                              
  532721    *USP42*           0.64                       0.02                                                              
  518458    *SEMA6D*          0.64                       0.02                                                              
  539250    *KCNJ1*           0.64                       0.04                                                              
  536818    *LOC536818*       0.64                       0.03                                                              
  534063    *EIF2B3*          0.65                       0.001                                                             

**Notes:**

SCE = subclinical uterine infection (endometritis). NUI = no uterine infection.

###### 

Expression of genes associated with inflammation, oxidative stress and metabolism in liver tissue from healthy cows (no uterine infection, NUI) or cows with subclinical endometritis (SCE). Data were generated via quantitative RT-PCR.

                                         GROUP                    
  -------------------------------------- --------- ------- ------ ------
                                                                  
  **Transcription regulators**                                    
                                                                  
  *PPARA*                                −0.19     −0.09   0.24   0.78
                                                                  
  *RXRA*                                 0.38(↑)   0.11    0.10   0.06
                                                                  
  *NFIL3*                                0.60      0.54    0.30   0.87
                                                                  
  **Fatty acid oxidation**                                        
                                                                  
  *ACOX1*                                0.23      0.32    0.14   0.64
                                                                  
  *CPT1A*                                0.25      0.20    0.17   0.82
                                                                  
  **Ketogenesis**                                                 
                                                                  
  *HMGCS2*                               0.23      0.35    0.24   0.72
                                                                  
  **GH/IGF-1 axis**                                               
                                                                  
  *GHR*                                  0.53(↑)   0.19    0.16   0.05
                                                                  
  *IGF1*                                 0.25      0.24    0.27   0.96
                                                                  
  **Cytokines/inflammatory mediators**                            
                                                                  
  *IL10*                                 −0.29     0.33    0.51   0.38
                                                                  
  *IL1B*                                 0.22      0.32    0.35   0.84
                                                                  
  *TNF*                                  0.28      0.57    0.37   0.57
                                                                  
  *STAT3*                                0.50      0.21    0.18   0.25
                                                                  
  *SOCS2*                                0.23      −0.40   0.40   0.27
                                                                  
  *STAT5B*                               0.08      0.13    0.08   0.71
                                                                  
  **Acute-phase proteins**                                        
                                                                  
  *ORM1*                                 0.13      0.10    0.49   0.96
                                                                  
  *HP*                                   0.41(↑)   −1.03   0.69   0.04
                                                                  
  *SAA3*                                 −0.36     −0.75   0.68   0.69
                                                                  
  *PON1*                                 0.32      0.10    0.15   0.30
                                                                  
  **Oxidative stress**                                            
                                                                  
  *SOD2*                                 0.42(↑)   0.05    0.13   0.04
                                                                  
  *GPX1*                                 0.44(↑)   −0.05   0.20   0.08
                                                                  
  **Hepatokines**                                                 
                                                                  
  *ANGPTL4*                              0.11      −0.05   0.35   0.74
                                                                  
  *FGF21*                                −0.65     −0.51   0.92   0.91
                                                                  
  **Insulin signaling**                                           
                                                                  
  *AKT1*                                 −0.63     −0.69   0.11   0.72

###### 

Expression of genes associated with inflammation, oxidative stress and metabolism in subcutaneous adipose from healthy cows (no uterine infection, NUI) or cows with subclinical endometritis (SCE). Data were generated via quantitative RT-PCR.

                                         GROUP                     
  -------------------------------------- ---------- ------- ------ --------
                                                                   
  **Transcription regulators**                                     
                                                                   
  *RXRA*                                 −1.30      −0.71   0.37   0.28
                                                                   
  *PPARG*                                1.49       1.63    0.18   0.60
                                                                   
  *SREBF1*                               0.80       1.15    0.31   0.44
                                                                   
  *TP53*                                 1.23(↑)    −0.20   0.44   0.04
                                                                   
  *NFIL3*                                0.68       0.44    0.12   0.20
                                                                   
  **Lipogenic enzymes**                                            
                                                                   
  *LPIN1*                                −0.15      0.16    0.32   0.50
                                                                   
  *SCD*                                  −1.21      −0.12   0.80   0.36
                                                                   
  *FASN*                                 0.26       0.31    0.33   0.91
                                                                   
  *PLIN2*                                −1.86(↓)   0.20    0.57   0.02
                                                                   
  **Lipolytic-related (lipolysis)**                                
                                                                   
  *ABHD5*                                0.09       0.08    0.26   0.98
                                                                   
  *LIPE*                                 0.14       −0.10   0.19   0.38
                                                                   
  *PNPLA2*                               0.15       0.45    0.19   0.26
                                                                   
  **Insulin signaling**                                            
                                                                   
  *GHR*                                  −0.09      −0.08   0.30   0.98
                                                                   
  *SLC2A4*                               0.82(↓)    1.44    0.21   0.03
                                                                   
  *IRS1*                                 −1.69(↓)   −1.02   0.13   \<0.01
                                                                   
  **Adipokines and hepatokines**                                   
                                                                   
  *ADIPOQ*                               0.73       0.77    0.68   0.97
                                                                   
  *ANGPTL4*                              −0.07      −0.06   0.27   0.98
                                                                   
  *CCL5*                                 −1.23      −1.26   0.52   0.98
                                                                   
  *BCL2*                                 −0.70      −0.48   0.31   0.62
                                                                   
  *CCL2*                                 −1.34(↑)   −3.62   0.46   \<0.01
                                                                   
  **Oxidative stress**                                             
                                                                   
  *SOD2*                                 −2.44(↓)   0.99    1.22   0.06
                                                                   
  **Cytokines/inflammatory mediators**                             
                                                                   
  *IL6*                                  0.36(↑)    −2.27   0.33   \<0.01
                                                                   
  *HP*                                   −1.74      −1.20   0.51   0.46
                                                                   
  *SAA3*                                 −2.64      −0.68   1.26   0.29
                                                                   
  *NFKB1*                                1.26       0.98    0.28   0.98
                                                                   
  *STAT3*                                1.68       0.96    0.35   0.16
